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Abstract
To determine critical host factors involved in HIV-1 replication, a dominant effector genetics approach was developed to
reveal signaling pathways on which HIV-1 depends for replication. A large library of short peptide aptamers was expressed
via retroviral delivery in T cells. Peptides that interfered with T cell activation-dependent processes that might support HIV-1
replication were identified. One of the selected peptides altered signaling, lead to a difference in T cell activation status, and
inhibited HIV-1 replication. The target of the peptide was JAB1/CSN5, a component of the signalosome complex. JAB1
expression overcame the inhibition of HIV-1 replication in the presence of peptide and also promoted HIV-1 replication in
activated primary CD4+ T cells. This peptide blocked physiological release of JAB1 from the accessory T cell surface protein
LFA-1, downstream AP-1 dependent events, NFAT activation, and HIV-1 replication. Thus, genetic selection for intracellular
aptamer inhibitors of host cell processes proximal to signals at the immunological synapse of T cells can define unique
mechanisms important to HIV-1 replication.
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Introduction
In primary T cells, productive HIV-1 replication occurs only in
activated T cells. Therefore essential host processes and molecules
that support HIV-1 replication become uniquely available to HIV-
1 during T cell activation [1,2,3]. This activation process is
initiated by the interaction of the T cell antigen receptor (TCR)
with antigen-derived peptide bound to the major histocompatibil-
ity complex (MHC) molecule on the antigen presenting cell (APC)
[4]. This cell-cell interaction encourages formation of the
immunological synapses that form at the interface between a T
cell and an APC [5,6]. The immunological synapse, consisting of a
central cluster of TCR and an outer ring of adhesion molecules,
including leukocyte function-associated antigen-1 (LFA-1), CD28,
and other surface proteins, is a necessary structure for T cell
activation [7], although, it is unclear how these surface molecules
regulate T cell activation status. The importance of signaling
events initiated at the synapse in HIV-1 replication is not well
understood.
As has been previously shown, T cell activation signals allow
finalization of reverse transcription, nuclear translocation, inte-
gration, and transcription from the HIV-1 promoter [2,8,9,10].
Signaling systems downstream of TCR engagement, IL-2, and
other surface receptors have been implicated in creating a milieu
that is conducive to productive HIV-1 infection in primary T cells
[11]. HIV-1 replication spontaneously occurs in many CD4+ T
cell lines in which host molecules necessary for HIV replication are
constitutively active, but does not in primary CD4+ T cells.
Understanding such differences allows us to exploit molecular and
genetic interventions to gain insight into HIV-1 biology in human
cells and to provide new targets for anti-HIV therapy.
In this report, the COP9 signalosome component JAB1/CSN5
was identified as the target molecule of a peptide aptamer that
inhibited HIV-1 replication in a genetic screen. JAB1 interacts
with the cytoplasmic domain of the integrin LFA-1, an adhesion
molecule present during formation of the immunological synapse.
Engagement and activation of LFA-1 through the immunological
synapse initiates relocalization of JAB1, leading to enhanced JNK
activity important for early T cell activation events [12]. The
selected aptamer blocked this LFA-1-induced JAB1 relocalization
event and downstream JNK activity resulting in inhibition of HIV-
1 replication. Therefore, the data in this report link HIV-1
replication to early T cell activation events that are concomitant
with, or that follow, signaling from the immunological synapse.
Results
Selection of Intracellular Aptamers that Inhibit HIV-1
Transcription Through Action Upon NFAT and AP-1
Signaling Systems
A dominant effector genetic screen was implemented to identify
trans-acting peptides that act upon T cell signaling processes
important to HIV-1 replication. The basis of the approach was
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retroviral expression of short peptides (10-mers) from a library of
more than 107 different members in T cells followed by selection
for phenotypes dependent upon peptide expression. The retrovi-
ruses were designed to express both a peptide and GFP from a
single transcript (Figure 1); GFP was used as a surrogate indicator
of relative peptide expression in cells. The majority of peptides
expressed within cells were expected to have no effect on cellular
processes [13,14], [15], and detrimental global effects on the
viability of cells after expression of such libraries were not
observed. As is the case with pharmaceutical screens that evaluate
libraries of small organic molecules in high-throughput screening
assays, certain rare peptides of the right sequence and shape were
expected to interfere with intracellular signaling to give a desired
phenotypic outcome when those peptides are expressed within
cells.
T cell activation can be induced using the pharmacological
activator PHA–this activator mimics some processes of T cell
activation through action upon T cell surface receptors. The
ensuing stimulation releases intracellular calcium stores and
activates calcineurin and Nuclear Factor of Activated T cells
(NFAT), among other events [16], [17]. The normal T cell
activation program leads to activation of IL-2 and other
downstream genes, but can also activate HIV-1 replication and
transcription [1,2,9,10,18]. To identify peptides that dominantly
interfere with T cell activation-dependent HIV-1 replication, the
genetic strategy shown in Figure 1 was used. A stable Jurkat cell
line was established by transfection with a dipA gene driven by the
HIV-1 promoter, pHIV-LTR dipA puroR. This stable cell line,
Jurkat HIV-LTR dipA, can be killed by stimuli that activate HIV-
1 LTR activity such as PHA and Tumor Necrosis Factor-a (TNF-
a) [19,20]. These T cells were expected to survive if an expressed
peptide blocked signaling that led to HIV-1 promoter activation.
A high titer retroviral supernatant of the peptide library was
produced using the retroviral producer cell line Phoenix-Ampho
[21] and was used to infect 36108 recipient Jurkat HIV-LTR dipA
cells at about a 30% infection rate as measured by GFP expression
on a per cell basis. One week after retrovirus transduction, the cells
were stimulated with PHA. This stimulation was repeated six times
at regular intervals over two months–each cycle of stimulation was
expected to enrich for peptide-induced survivors against a
background of non-heritable spontaneous survival events (i.e.,
cells that survived due to epigenetic events, to not receiving
sufficient signal, or to other non-peptide effects). After the sixth
PHA stimulation, GFP-positive surviving cells were isolated by
flow cytometry. Approximately 5% of the cells were GFP-positive
at this stage. After culturing the cells for an additional 14 days,
total cellular DNA was prepared from these cells. Using primers
specific to constant regions flanking the peptide insert, the peptide
Figure 1. Overall strategy for screening using retrovirus peptide library. The retroviral peptide expression library is first transfected into the
helper-free retroviral producer line by transient transfection. The supernatant containing the retrovirus-encoded peptide expression library is used to
infect target Jurkat HIV-LTR dipA cells. The cells are subjected to PHA treatment, and GFP positive cells are selected and grown (GFP+ cells should be
peptide expressing and should enriched after selection). Genomic DNA is derived from the sorted cells. PCR amplified DNA, using primers flanking the
peptide inserts, was cleaved with restriction endonucleases and recloned into new vectors for retesting.
doi:10.1371/journal.pone.0041725.g001
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regions of the genes expressed in these cells were amplified and
subcloned into pBMN-IRES-GFP retrovirus vector. Plasmid
DNAs prepared from these fragments were transfected back into
Phoenix-Ampho to prepare recombinant retroviral supernatants
for retesting. These retroviral supernatants were transduced into
fresh Jurkat HIV-LTR dipA cells as in the original screen (see
above). Several clones were capable of potent inhibition of HIV
replication upon HIV-1 transcription. One of these clones, Pep24,
was further examined.
To begin to understanding how this peptide interfered with T
cell activation processes, relevant signaling pathways that might be
altered by peptide expression were examined. The most critical
cis-regulatory elements in the HIV-1 LTR are the kB regulatory
elements that can be activated by NF-kB or NFAT [9], [18], [22],
[23]. The selected peptide clone, Pep24, as well as four control
peptide clones (Figure 2A), were transduced into Jurkat cells using
retroviral delivery, and cells were sorted by flow cytometry to
select for those that expressed GFP. After culturing the selected
cells and retesting, greater than 98% of cells were positive for GFP,
and therefore peptide, expression. Luciferase reporter plasmids
driven either by three tandemly repeated NFAT binding sites
(from the IL-2 gene) [24] or by three tandemly repeated NF-kB
binding sites (from the Igk chain) [25] were transfected into these
peptide-expressing cells. With TNF-a stimulation, comparable
transcriptional activity was observed in clones expressing the
control peptides and Pep24 and the NF-kB reporter (Figure 2B).
With PHA plus PMA stimulation of cells expressing the control
peptides and the NFAT specific reporter plasmid, there was the
expected NFAT activation; however, no NFAT-driven transcrip-
tional activity was observed in cells expressing Pep24 (Figure 2C).
Although NFAT transcriptional activity was inhibited by Pep24,
we did not observe the inhibition of NFAT nuclear translocation
by Pep24 after PHA plus PMA stimulation by western blot analysis
using nuclear extracts (data not shown).
We then examined the effect of Pep24 upon the AP-1 signaling
pathway. AP-1 associates with the Rel domain of NFAT to control
transcription of various genes upon T cell activation [16,26,27].
An AP-1 specific reporter plasmid (driven by five tandemly
repeated AP-1 binding sites) [16] was transfected into Jurkat cells
that expressed control peptides or Pep24. With PHA plus PMA
stimulation, Jurkat cells that did not express peptide and the Jurkat
cells expressing control peptide had similar levels of transcription
activity. In Pep24 expressing Jurkat cells, however, AP-1 induced
transcription activity was inhibited (Figure 2D). Thus, Pep24
inhibited AP-1 and NFAT signaling pathways but not the NF-kB
pathway. Our data suggest that the inhibition of NFAT signaling
by Pep24 may be due to an inhibition of AP-1 activation, as AP-1
is a fundamental part of the NFAT holoprotein complex
[16,26,27].
Pep24 Inhibits JNK Activity
With this initial understanding of how Pep24 interfered with T
cell activation processes, the kinase activity of Jun N-terminal
Kinase (JNK) and extracellular signal-regulated kinase (ERK) in
Jurkat cells expressing C-Pep1 and Pep24 were examined using
FACS-based intracellular phospho-protein analysis. JNK is
activated by stress stimuli and pro-inflammatory cytokines and
phosphorylates c-Jun and JunD, which are important components
necessary for AP-1 transcription. ERK is thought to be crucial for
many T cell signaling events and should serve as a control to
measure how Pep24 inhibition affected other signaling events in T
cells. In C-Pep1-expressing SupT1 cells, JNK was activated by
PMA and PHA stimulation, but JNK activation in Pep24
expressing cells was strongly inhibited (Figure 3). Pep24 did not
inhibit anisomicin-induced JNK activity. Anisomycin is an
inhibitor of protein synthesis at the translation step and strongly
activates stress-activated protein kinase (JNK/SAPK). Thus, these
experiments indicate that JNK induction by PMA and PHA was
dependent on a target molecule of Pep 24, whereas anisomicin-
induced JNK activity was independent of a target molecule of Pep
24. Pep24 did not influence ERK activity (Figure 3), showing that
Pep24 is not a global inhibitor of T cell signaling events.
COP9 Signalosome Component JAB1/CSN5 as a Target of
Aptamer Inhibition of HIV-1 Replication
A yeast two hybrid screen was used to identify the target
molecule of Pep24. In a screening using Pep24 as bait, Jun
activating binding protein (JAB1) was isolated. JAB1 was originally
identified as a co-activator of the c-Jun and JunD, and was shown
to be capable of acting to increase specific gene transcription
driven by the AP-1 protein [28,29]. JAB1 has also been called
COP9 signalosome subunit 5 (CSN5) [30], as it is a component of
the COP9 signalosome regulatory complex (CSN). The COP9
signalosome has kinase activity towards some cellular targets,
including c-Jun and p53 [28,31]. JAB1/CSN5 participates in
inflammatory cascades, cell cycle regulation, apoptosis, carcino-
genesis, and immunity, all as a signalosome component
[12,29,32,33,34,35].
To determine whether Pep24 specifically bound to JAB1,
affinity binding experiments were performed using a recombinant
GST-JAB1 fusion protein and biotin-conjugated peptides. Pep24
bound to the GST-JAB1 fusion protein, but did not bind to GST
alone. The control peptide, C-Pep1, did not bind to either GST-
JAB1 or GST (Figure 4). This indicates a specific affinity of Pep24
for JAB1 and also rules out the possibility of non-specific binding
between JAB1 and the Gal4 DNA-binding domain that has caused
false positive signals in the Gal-4-based yeast two-hybrid system
[36].
To examine whether Pep24 inhibits HIV-1 replication and
whether inhibition can be recovered by JAB-1 expression, control
(pBMN control IRES-Lyt2a’) or JAB1-expressing (pBMN JAB1
IRES-Lyt2a’) retroviral vectors were transduced with or without
C-Pep1 or Pep24 expression vectors into SupT1 cells. SupT1 cells
that expressed JAB1 or control constitutively (Lyt2a’ positive) and
C-Pep1 or Pep24 (GFP positive) were selected by flow cytometry.
These cells were then challenged by HIV-1 (NL4-3) and p24 levels
were determined. Pep24 strongly inhibited HIV-1 replication
when compared with cells expressing C-Pep1 (Figure 5A). JAB1
expression alone did not alter HIV-1 replication in SupT1 cells.
The inhibition of HIV-1 replication by Pep24 was partially,
though not completely, overcome by JAB1 expression (Figure 5A).
The partial restoration of HIV-1 replication in cells expressing
both JAB1 and Pep24-expressing cells is likely caused by binding
of excess JAB1 to the inhibitor Pep24. Of note, JAB1 fully restored
the inhibition of HIV-1 replication by another HIV-1 inhibitor
peptide, Pep107, even though Pep107 did not bind JAB1 in our
yeast two hybrid assay (unpublished data). Although the host
target molecule of Pep107 was not identified, these data suggest
that Pep107 binds to a factor in the same signaling cascade and
limits the availability of functional JAB1 or that ectopic JAB1
expression can overcome a limitation imposed by Pep107 action
on that unknown factor. These data support the conclusion that
JAB1 is a bona fide target molecule of Pep24. Non-transduced, C-
Pep1 expression or JAB1 expression alone did not alter HIV-1
replication in SupT1 cells (Figure 5B).
To examine whether JNK inhibition by Pep24 is involved in the
inhibition of HIV-1 replication, we carried out an HIV-1
replication assay using JNK inhibitor, SP600125. SP600125
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inhibits JNK kinase activity by competing with ATP for its binding
site. SP600125 less potently inhibits activity of MAP kinases as
well. SP600125 significantly reduced HIV-1 replication compared
with non-treated cells at each time point in a dose-dependent
manner (Figure 5C). This further supports the hypothesis that
JNK, acting downstream of JAB1, is a critical kinase on which
HIV-1 depends for its replication.
To determine whether JAB1 could affect HIV-1 replication in
primary CD4+ T cells, HIV-1 replication was measured in
primary CD4+ T cells with or without ectopic JAB1 expression.
JAB1 was retrovirally transduced into primary CD4+ T cells.
Control primary CD4+ T cells and JAB1-expressing primary
CD4+ T cells were infected with NL4-3, and HIV-1 replication
levels were measured by a p24 ELISA. After 18 days, most cells
were dead and the experiment was terminated. No HIV-1
replication was observed in either control or JAB1-expressing
non-stimulated primary CD4+ T cells. However, after PHA
stimulation, HIV-1 replication was enhanced about four fold in
JAB1-expressing primary CD4+ T cells in comparison with control
primary CD4+ T cells (Figure 6). This shows that T cell activation
and JAB1 activity are required for HIV-1 replication in primary
CD4+ T cells. It can be concluded that endogenously expressed
JAB1 is acted upon during T cell activation to enhance signaling
important to HIV-1 replication.
Pep24 Inhibits LFA-1-induced JAB1 Relocalization
To determine how Pep24 influences JAB1 function, we
examined JAB1 localization in Pep24-expressing Jurkat cells by
a confocal microscope analysis. JAB1 binds to the cytoplasmic tail
of the beta chain of the LFA-1 surface protein [12]. Engagement
of LFA-1 with activating ligands (ICAMs 1, 2 or 3) or crosslinking
with activating antibodies results in release of JAB1 into the
cytoplasm and nucleus [12]. As expected, JAB1 was localized at
the membrane when Jurkat cells were not stimulated (Figure 7A
and G). After cross-linking with anti-LFA-1 monoclonal antibody
(mAb) JAB1 was redistributed to the cytoplasm and nucleus in C-
Pep1-expressing Jurkat cells (Figure 7D). In cells expressing Pep24,
however, JAB1 remained at the membrane (Figure 7J), indicating
that Pep24 blocks JAB1 relocalization. Taken together, this
suggests that by preventing JAB1 relocalization, Pep24, leads to
inhibition of AP-1 function and NFAT activity and ultimately
blocks critical events required for HIV-1 replication.
Discussion
The peptide, Pep24, was selected from a peptide library in a
dominant effector genetics approach for its ability to represses
host pathways that are important for HIV-1 replication in T
cells. Pep24 was used as ‘bait’ to identify the host factor JAB1
as an important component that regulates HIV-1 replication in
Figure 2. Selected peptide, Pep24, preferentially inhibits the NFAT signaling pathway. (A) The sequences of control peptides and
selected peptide. (B–D) Reporter plasmids (B) p55-IgkLuc, (C) NFAT Luc, or (D) AP-1 Luc were transfected into Jurkat cells expressing indicated
peptides with pBMN LacZ as the internal control plasmid. Cells treated for 3 hr (8 hr for AP-1) with or without indicated agents (2 mg/ml PHA, 10 ng/
ml PMA, and 10 ng/ml TNF-a) prior to measurement of luciferase activity. The experiments were repeated three times and the average is plotted 6
SE. Jurkat cells transfected with reporter without treatment were assigned a value of 1 and were used to calculate the fold activation. Transfection
efficiencies were normalized to a co-transfected lacZ plasmid.
doi:10.1371/journal.pone.0041725.g002
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T cells. JAB1 (also known as CSN5) is involved in the activation
of c-Jun, a component of the AP-1 heterodimeric transcription
factor [28]. Pep24 inhibited relocalization of JAB1 post-LFA-1
engagement, downstream signaling pathways, and, therefore,
HIV-1 replication (Figure 8). As JAB1 enhanced HIV-1
replication only in PHA-activated primary CD4+ T cells,
JAB1 is a mediator of HIV-1 replication only after appropriate
signaling primes its activity.
JAB1 interacts with the b subunit of the cytoplasmic domain
of the integrin, LFA-1, and contributes to integrin-mediated
signal transduction [12]. The interaction of LFA-1 with ICAM-
1, ICAM-2, or ICAM-3 is critical for formation of the
immunological synapse during full T cell activation [7,37,38].
The kinetics of induction of LFA-1 are complex. In resting T
cells, a low affinity form of LFA-1 is present at the cell surface.
The interaction of specific antigen and TCR induces intracel-
lular signals to convert LFA-1 to a high-affinity state [37] that,
in concert with engagement of ICAM ligands, can transduce
signals that allow for JAB1 release. After appropriate engage-
ment, JAB1 redistributes to the cytoplasm and nucleus where it
can activate AP-1 transcriptional activity required for T cell
activation [12]. Interestingly LFA-1 was previously implicated as
a promoter of HIV-1 transmission during virus entry and
replication [11,39,40,41,42] A mutant of LFA-1 that cannot
bind with high affinity to ICAM-1 fails to promote HIV-1
replication in spite of the fact that this mutant LFA-1 promoted
virus entry into cells [11], suggesting that an LFA-1 mediated
signal is required to promote a replicative environment for
HIV-1 in T cells. It has also been reported that HIV-1 infected,
Nef-expressing macrophages shed soluble CD23 and soluble
ICAM that are HIV-1 replication permissivity factors for
primary resting T cells [43]. This supports our finding that
the ICAM/LFA-1 interaction and the ensuing activation of the
JAB1 signaling pathway are critical for HIV-1 replication in T
cells. Taken together, current data suggest that the formation of
the APC::T cell junction, LFA-1 engagement, and subsequent
signaling that releases JAB1 and activates the transcriptional
regulators AP1 and NFAT (initial immutable events during T
cell activation) leads to a molecular outcome that facilitates
HIV-1 replication.
JAB1 is thought to interact with many proteins such as
p27kip1, macrophage migration inhibitory factor 1 (MIF1), c-Jun,
LFA-1, Bcl-3, and steroid receptor co-activator (SRC-1)
[12,29,32,33,44,45]. The functions of JAB1 in these interactions
are not well understood. JAB1/CSN5 has been shown to
Figure 3. JNK is one of kinases on which HIV-1 depends. Jurkat cells expressing C-Pep1 or Pep24 were treated with indicated stimuli. Cells
were stained with pERK-Alexa 647 or pJNK-Alexa 647 phosphospecific antibodies and analyzed by flow cytometry. (A) Histograms are colored
according to the different stimuli. (B) Fold change was approximated by calculating the log2 ratio of mean fluorescence intensity of stimulated versus
unstimulated cells.
doi:10.1371/journal.pone.0041725.g003
Figure 4. Pep24 specifically binds to JAB1. The indicated biotin-
conjugated peptides were incubated with GST or with the GST-fused
JAB1. The complex of peptide-GST fusion protein immobilized on
streptavidin-agarose was detected by western blotting with anti-GST
antibody.
doi:10.1371/journal.pone.0041725.g004
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contain a JAMM domain and support an isopeptidase in the
COP9 signalosome in the removal of the ubiquitin-like Nedd8
from the Cul1 subunit of SCF ubiquitin ligase [46]. It is known
that JAB1 engagement of p27kip1 allows a cell to proceed
through the G1 phase of the cell cycle [33]. Based on these
results, we hypothesized that the binding to JAB1 by Pep24 led
to a blockade of JAB1 function. If the interaction of JAB1 and
Pep24 prevents the binding to p27kip1 by JAB1 there should be
cell cycle arrest. However, this was not observed in Pep24-
expressing T cell (data not shown). This suggests that Pep24
binds to a region of JAB1 that effects regulation of c-Jun but
not p27kip1. It is also possible that the peptide binds to a region
of JAB1 that must be post-translationally modified to allow its
release from LFA-1. If so, the Pep24-JAB1 interaction site could
be a locus for design of small molecule regulators of specific T
cell functions, including those that either distinctly, or spatially,
inhibit this aspect of T cell activation, to block HIV-1
replication. Importantly, JAB1 has not previously been identified
as a potential drug target. As the JNK inhibitor SP600125
[47,48,49] blocked HIV-1 replication in a dose-dependent
manner, specific MAP kinase-related events downstream of
JAB1 facilitate HIV-1 replication.
In this study, intracellular peptide display technology was used
to identify host factors critical to HIV-1 replication pathways. Host
factors defined in this manner are candidates for drug develop-
ment. Inhibitors that block virus access to necessary host factors
may be less likely to result in drug resistance than drugs targeting
viral proteins. This dominant effector screening approach might
also be applied as an adjunct to classical analysis of signaling
systems to provide a series of inhibitors that define complemen-
tation groups. A unique involvement of LFA-1 signaling via JAB1
that is involved in T cell activation and enables HIV-1 replication
in cells was demonstrated. The intriguing role of JAB1 in early T
cell activation events that drive HIV-1 replication underscores a
need for new tools for identification of early and late host processes
required for pathogen parasitism.
Figure 5. JAB1 overcomes the inhibition of HIV-1 replication in cognate peptide expressing SupT1 cells. (A) pBMN-control IRES-Lyt2a’
or pBMN-JAB1 IRES-Lyt2a’ retrovirus vectors were transduced into SupT1 cells that expressed either C-Pep1 or Pep24. (B) pBMN-control IRES-Lyt2a’ or
pBMN-JAB1 IRES-Lyt2a’ retrovirus vectors were transduced into SupT1 cells. These cells were challenged with HIV-1 (NL4-3) at a dose 400 TCID50 per
56104 cells. p24gag levels in culture supernatants were assayed from four wells on the indicated days after infection. p24gag levels were normalized to
cell number determined using an XTT assay. Data are presented as the average6 SE per 106 cells. Similar results were observed in three independent
experiments. * indicates p,0.05, Control C-Pep-1 SupT1 versus Control Pep24 SupT1, and # indicates p,0.05, Control Pep24 SupT1 versus JAB1
Pep24 SupT1 by t test. (C) JNK inhibitor (SP600125) inhibits HIV-1 replication. SupT1 cells were treated JNK inhibitor (SP600125) for 30 min before HIV-
1 challenge. These cells were challenged with HIV-1 (NL4-3) at a dose 400 TCID50 per 5610
4 cells. p24gag levels in culture supernatants were assayed
from five wells on the indicated days after infection. p24gag levels were normalized for cell number using XTT assay. Data are presented as the
average6 SE per 106 cells. Similar results were observed in three independent experiments. *indicates p,0.05, No treatment versus 10 mM SP600125,
and # indicates p,0.05, No treatment versus 30 mM SP600125 by t test.
doi:10.1371/journal.pone.0041725.g005
Figure 6. JAB1 promotes HIV-1 replication in activated primary
CD4+ T cells. pBMN-control-IRES-Lyt2a’ and pBMN-JAB1-IRES-Lyt2a’
retrovirus vectors were transduced into human primary CD4+ T cells.
CD4+ T cells were challenged with HIV-1 (NL4-3) at doses of 400 TCID50
per 16105 cells with or without PHA stimulation. p24gag levels in culture
supernatants were assayed from four wells on the indicated days after
infection. p24gag levels were normalized for cell number determined
using an XTT assay. Data are presented as the average 6 SE per 106
cells. Similar results were observed in three independent experiments.
doi:10.1371/journal.pone.0041725.g006
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Figure 7. Pep24 blocks LFA-1-induced JAB1 relocalization. Jurkat cells expressing indicated peptides were adhered to either anti-LFA-1 mAb
or control IgG coated plates for 30 min. After cross-linking stimulation, cells were stained for JAB1 (red). GFP (green) is an indicator of peptide
expression. (A–C) C-Pep1-expressing cells without stimulation. (D–F) C-pep1-expressing cells with LFA-1 cross-linking stimulation. (G–I) Pep24-
expressing cells without stimulation. (J–L) Pep24-expressing cells with LFA-1 cross-linking stimulation.
doi:10.1371/journal.pone.0041725.g007
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Materials and Methods
Plasmid Construction
The pHIV-LTR dipA puroR consists of the HIV-1 long
terminal repeat (LTR containing the enhancer and promoter
region; 2520/+81) linked to cDNA of the diphtheria toxin A
chain gene. The polyadenylation site was derived from SV40.
Downstream of this was placed the puromycin resistance gene
driven from the CMV promoter and the polyadenylation site was
derived from SV40. The sequence of control peptides (C-Pep1-4)
and Pep24 were inserted into the retroviral expression vector
pBMN-IRES-GFP using BamHI and SalI sites. The coding
sequence of JAB1 was inserted into retroviral expression vector
pBMN-IRES-Lyt2a’ using BamHI and SalI. pEBG-JAB1 was
constructed by inserting the cording sequence of the JAB1 into a
eukaryotic glutathione-S-transferase (GST) expression vector
pEBG.
Construction of Random Peptide Library
The library insert was constructed using an oligonucleotide with
the following sequence 59-AGCTAGATCGCAGTGTGCCAC-
CATGGNK(NNK)8TGACTGACTGAGTCGACATCG-39
where N was a mixture of each of the four nucleotides and K was a
mixture of G and T. The DNA oligonucleotide library template
was amplified by five rounds of PCR using the primers 59-
AGCTAGATCGCAGTGTGCCACCATG-39 and 59-
CTCGAGTCAGTCAGTCA-39. The appropriately sized frag-
ment was gel purified and ligated into pBMN-IRES-GFP using
BamHI and SalI sites. The ligated DNA was transformed into
STBL4 electrocompetent E. coli cells (Invitrogen) according to the
manufacturer’s protocol. The peptide library contained 2.96107
independent clones.
Screening of Peptide Library and Rescue of Survivor
Peptides
Recombinant retroviruses representing the peptide library were
prepared using the Phoenix Ampho retrovirus packaging cell line
[21] and used to infect 36108 Jurkat HIV-LTR dipA cells as
described previously [9]. The cells infected with the peptide library
were stimulated with 2 mg/ml phytohaemaglutinin (PHA) six times
over a period of 2 months. During this selection period, cells were
cultured in RPMI 1640 containing 2.5% fetal calf serum (FCS).
After this selection, GFP-positive living cells were sorted by flow
cytometry, and total cellular DNA was prepared from these cells
using the QIAamp Blood Kit (QIAGEN). The DNA was amplified
by PCR using primers described above. The PCR fragment was
ligated into pBMN-IRES-GFP, and this DNA was transformed
into E. coli as described above.
Luciferase Assay
Jurkat cells and peptide-expressing Jurkat cells were cultured in
RPMI 1640 containing 10% FCS. The luciferase assay was
performed as described previously [9]. Cells (16106) were
transfected with 1 mg of reporter plasmid, 1 mg of indicated
plasmid, and 1 mg pBMN LacZ using the FuGENE6 transfection
reagent according to the manufacturer’s protocol (Roche Applied
Science). Thirty-six hours after transfection, cells were treated as
indicated, and luciferase activity was measured in cell extracts.
LacZ activity was assayed by standard methods.
HIV Infection and p24 Assay
SupT1 cells (CRL-1942, ATCC) and SupT1 cells expressing
peptides were cultured in RPMI 1640 medium containing 2.5%
FCS. HIV-1 infection and p24 assays were performed as described
previously [9,10]. Cells were infected with HIV-1 by incubating
cells with NL4-3 (for SupT1 cells, 400 TCID50/56104 cells; for
primary CD4+ T cells, 400 TCID50/16105 cells) in 0.5 mL of
culture medium at 37uC for 4 hr. After HIV-1 challenge, cells
were washed with culture medium and plated in five wells of a 48-
well plate (for SupT1 cells, 56104 cells/well; for primary CD4+ T
cells, 16105 cells/well). Virus replication was measured on the
indicated days after HIV-1 challenge by p24 ELISA according to
the manufacturer’s protocol (ZeptoMetrix Corporation). p24gag
levels were normalized to cell number measured using the XTT
assay.
For the replication assay in the presence of the JNK inhibitor,
SupT1 cells were treated with 10 mM or 30 mM JNK inhibitor,
SP600125 (S5567, SIGMA) at 37uC for 30 min before HIV-1
challenge. Treated cells were challenged with NL4-3 (400
TCID50/5610
4 cells in 0.5 mL of culture medium). Virus
Figure 8. Proposed model for the inhibition of signalling pathway by Pep24. (A) After LFA-1 activation, JAB1 relocalizes into cytoplasm and
nucleus, activates AP-1 and induces gene activation, and finally activates HIV-1 replication. (B) When Pep24 binds to JAB-1, JAB1 relocalization is
blocked inhibiting downstream signals and HIV-1 replication.
doi:10.1371/journal.pone.0041725.g008
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replication was measured on the indicated days by p24 ELISA as
described above.
Phospho-specific Flow Cytometry
Phospho-specific flow cytometry was performed as described
previously [50]. Briefly, Jurkat cells expressing control (C-Pep1) or
Pep24 were treated with phorbol myristate acetate (PMA)
(50 nM), PHA (2 mM), the combination of PMA and PHA, or
anisomycin (2 mg/ml) for 30 min. The cells were then fixed with
1.6% formaldehyde, pelleted, permeabilized with 100% methanol,
and washed with staining media (phosphate buffered saline (PBS)
containing 0.5% bovine serum albumin (BSA) and 0.02% sodium
azide). Samples were stained with Alexa 647 labeled pERK
(#612358, BD Pharmingen) or Alexa 647 labeled pJNK (#9255S,
Cell Signaling) antibody (antibodies were labeled with Alexa 647
using the Invitrogen Zenon system according to the manufacture’s
protocol) and analyzed on a FacsCalibur flow cytometer (BD)
equipped with a 633-nm laser for detection of Alexa 647. GFP
positive cells were gated, and phospho-protein levels were
analyzed. Fold change (FC) was calculated as follows: FC=MFIs-
tim/MFIunstim, where MFI is the mean fluorescence intensity. Log2
conversion was performed for heat map visualization.
Yeast Two-hybrid Screening
Pep24 was fused in-frame to the Gal4 DNA binding domain
through a three-glycine spacer in the pAS2-1 GAL4 plasmid [13].
The pACT2-human leukocyte library (Clontech) was used for the
screening by the yeast two-hybrid method in Y190 yeast cells as
described [51] with minor modifications (40 mM 3-aminotriazole
was used in selection medium).
Affinity Binding Assay
The JAB1-glutathione S-transferase (GST) fusion protein was
purified using glutathione sepharose 4B (17-0756, GE Healthcare)
according to the manufacture’s protocol. The GST fusion protein
and biotin-conjugated peptides were incubated in binding buffer
(50 mM Tris-HCl (pH 7.5), 5 mM MgCl, 100 mM NaCl, 10%
glycerol, 2 mg/ml BSA, 5 mM b-mercaptoethanol) for 3 hr at
4uC with constant rotation. The complexes of GST fusion proteins
and peptides were immobilized on streptavidin agarose beads
(S1638, Sigma) overnight at 4uC with constant rotation. The beads
were washed four times with binding buffer and were boiled in
sample buffer (50 mM Tris-HCl (pH 6.8), 2% sodium dodecyl
sulfate, 1% bromophenol blue, 10% glycerol, 5% b-mercaptoeth-
anol). Eluted proteins were resolved by SDS-PAGE, and western
blot analysis was performed using anti-GST antibody (G1160,
Sigma) and anti-mouse-HRP conjugate (A9044, Sigma). Blots
were visualized with ECL Plus Western Blotting Detection System
(GE Healthcare).
Laser Scanning Confocal Microscopy
Jurkat cells (16106) were adhered to either anti-LFA-1 mAb-
coated (clone TS1/22, 20 mg/ml, Developmental Studies Hybrid-
oma Bank) or control IgG-coated 24-well plates by mild
centrifugation (2006g, 10 min) and incubated at 37uC for
30 min. Cells were then washed in PBS, pH 7.4 at 4uC and fixed
in 1% paraformadehyde (15 min, 4uC). Cells were permeabilized
for 15 min in perm buffer (0.2% saponin in PBS containing 5%
FCS), washed 1X in PBS and subjected to anti-JAB1 antibody
stain (SC-9021, Santa Cruz Biotechnology; 0.2 mg/50 mL perm
buffer), washed 2X in perm buffer, and stained with anti-rabbit-
Alexa 594 conjugate (A-11037, Molecular Probes; 0.1 mg/50 ml
perm buffer). Antibody stains were performed for 30 min at 4uC in
suspension. Cells were washed twice with perm buffer and adhered
to 96-well glass bottom plates (BD Biosciences) coated with
Prolong Gold antifade reagent (P36930, Molecular Probes) by
centrifugation (4506 g, 5 min). Cells were visualized by sequential
laser excitation using a Zeiss laser scanning confocal (LSM510)
and an oil immersion 63X objective. Images were acquired using
Zeiss LSM510 software and compiled using Adobe Photoshop
CS2.
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